Mark Stanley Berger
First SEC filing: Feb. 27, 2026 · Latest: Feb. 27, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | GNPX | F | 7,168 | $2.00 | $14,336 | 21,692 Direct | -24.84% | Disposed | -94.0% (price as of 2026-10-02) |
| Dec. 22, 2025 | GNPX | A | 28,500 | · | · | 28,860 Direct | +7916.67% | Acquired | (price as of 2026-10-02) |
| June 30, 2025 | GNPX | F | 4,500 | $0.23 | $1,035 | 17,971 Direct | -20.03% | Disposed | -99.0% (price as of 2026-10-02) |
| Feb. 18, 2025 | GNPX | F | 585 | $0.41 | $240 | 22,471 Direct | -2.54% | Disposed | -99.4% (price as of 2026-10-02) |
| Dec. 5, 2024 | GNPX | A | 18,250 | · | · | 23,056 Direct | +379.73% | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2024 | GNPX | F | 1,319 | $4.40 | $5,804 | 4,806 Direct | -21.53% | Disposed | -99.9% (price as of 2026-10-02) |
| Feb. 18, 2023 | GNPX | A | 245,000 | · | · | 245,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 4, 2022 | GNPX | A | 98,750 | · | · | 98,750 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 27, 2021 | GNPX | A | 550,000 | · | · | 550,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 4, 2022 | GNPX | Stock Option (right to buy) | Common Stock | $2.20 | Feb. 4, 2032 | 98,750 | Acquired |
| Sept. 27, 2021 | GNPX | Stock Option (right to buy) [F1] | Common Stock | $2.85 | Sept. 27, 2031 | 550,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $486,500 | $97,300 | $57,285 | · | · | · | $47,519 | $688,604 |
| 2024 | $486,500 | · | $19,710 | · | · | · | $45,505 | $551,715 |
| 2023 | $484,156 | $0 | $418,950 | · | · | · | $44,001 | $947,107 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.